APA (7th ed.) Citation

MA, G., B, S., Y, T., A, A., DOC, O., A, A., . . . IG, O. (2024). A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma. Journal of immunotherapy and precision oncology, 7(4), 247. https://doi.org/10.36401/JIPO-24-3

Chicago Style (17th ed.) Citation

MA, Gouda, et al. "A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma." Journal of Immunotherapy and Precision Oncology 7, no. 4 (2024): 247. https://doi.org/10.36401/JIPO-24-3.

MLA (9th ed.) Citation

MA, Gouda, et al. "A Phase Ib Study of Selinexor in Combination with Pembrolizumab in Patients with Metastatic Melanoma." Journal of Immunotherapy and Precision Oncology, vol. 7, no. 4, 2024, p. 247, https://doi.org/10.36401/JIPO-24-3.